Showing results (21-30 of 90) with videos related to
Sort By:
Pageof 9
Journal of Medicinal Chemistry|May 19, 2015
Discovery of Selective Small-Molecule Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction through the Optimization of the Acyl Hydrazone MoietyJ Leon Catrow, Yongqiang Zhang, Min Zhang, et al.Tetrahedron|May 29, 2012
Acid-Facilitated Debenzylation of N-Boc, N-Benzyl Double Protected 2-Aminopyridinomethylpyrrolidine DerivativesHaitao Ji, Qing Jing, Jinwen Huang, et al.Journal of Medicinal Chemistry|July 16, 2021
Discovery of 1-Benzoyl 4-Phenoxypiperidines as Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein InteractionZilu Li, Min Zhang, Kevin B Teuscher, et al.ACS Medicinal Chemistry Letters|May 19, 2022
New ZW4864 Derivatives as Small-Molecule Inhibitors for the β-Catenin/BCL9 Protein-Protein InteractionZhen Wang, Min Zhang, Harriet M Thompson, et al.Journal of Neuro-Oncology|September 28, 2010
α-Catenin inhibits glioma cell migration, invasion, and proliferation by suppression of β-catenin transactivationHaitao Ji, Ji Wang, Bingliang Fang, et al.Journal of Medicinal Chemistry|March 23, 2018
Structure-Based Optimization of Small-Molecule Inhibitors for the β-Catenin/B-Cell Lymphoma 9 Protein-Protein InteractionMin Zhang, Zhen Wang, Yongqiang Zhang, et al.Journal of Medicinal Chemistry|April 27, 2021
Discovery of 2-(3-(3-Carbamoylpiperidin-1-yl)phenoxy)acetic Acid Derivatives as Novel Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein InteractionZhen Wang, Min Zhang, Wen Luo, et al.ACS Chemical Biology|January 1, 2013
Rational design of small-molecule inhibitors for β-catenin/T-cell factor protein-protein interactions by bioisostere replacementBinxun Yu, Zheng Huang, Min Zhang, et al.ACS Medicinal Chemistry Letters|May 19, 2016
Structure-Based Design of 1,4-Dibenzoylpiperazines as β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction InhibitorsJohn A Wisniewski, Jinya Yin, Kevin B Teuscher, et al.ACS Chemical Biology|November 7, 2013
Targeting the Tcf4 G13ANDE17 binding site to selectively disrupt β-catenin/T-cell factor protein-protein interactionsZheng Huang, Min Zhang, Shawn D Burton, et al.Pageof 9